Integrated Pain Associates Expands Reach in Texas Through Partnership with Lubbock Spine Institute
Integrated Pain Associates partners with Lubbock Spine Institute to enhance access to minimally invasive pain management services in West Texas, marking a significant step in addressing unmet healthcare needs in underserved areas.

Integrated Pain Associates (IPA), a portfolio company of Triton Pacific Healthcare Partners, has announced a strategic partnership with Lubbock Spine Institute (LSI), a prominent provider of interventional spine and pain management services in West Texas. This collaboration extends IPA's services to Lubbock, Midland, and Amarillo, offering patients in these regions improved access to advanced, minimally invasive procedures aimed at treating the root causes of pain.
Dr. Scott Irvine, President of IPA, highlighted the shift in pain management towards minimally invasive procedures that offer better outcomes compared to traditional surgeries and medication management. The partnership with LSI is seen as a pivotal move to further this clinical model, combining IPA's expertise with LSI's skilled team of providers to deliver superior patient care.
Elodie Day, CEO of IPA, emphasized the challenges many pain management practices face due to operational complexity and limited training access. The alliance with LSI is expected to drive the paradigm shift in pain management, leveraging both organizations' strengths to benefit patients and providers alike.
Dr. Bolkar Sahinler of LSI expressed enthusiasm about the partnership, viewing it as an opportunity to build a differentiated platform that merges clinical excellence with strategic innovation. While the financial terms of the transaction remain undisclosed, the involvement of investors like Florac and Star Mountain underscores the significance of this partnership in the healthcare sector.
This partnership not only expands IPA's geographic footprint but also reinforces its mission to provide high-quality, accessible pain management solutions outside major metropolitan areas, ultimately aiming to reduce reliance on opioids and lower healthcare costs by avoiding high-cost hospital environments.